AR057123A1 - Composicion farmaceutica estable que contiene una pirimidina-sulfamida - Google Patents

Composicion farmaceutica estable que contiene una pirimidina-sulfamida

Info

Publication number
AR057123A1
AR057123A1 ARP060103943A ARP060103943A AR057123A1 AR 057123 A1 AR057123 A1 AR 057123A1 AR P060103943 A ARP060103943 A AR P060103943A AR P060103943 A ARP060103943 A AR P060103943A AR 057123 A1 AR057123 A1 AR 057123A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
sulfamide
pyrimidine
composition containing
stable pharmaceutical
Prior art date
Application number
ARP060103943A
Other languages
English (en)
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26070369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR057123(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of AR057123A1 publication Critical patent/AR057123A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

Reivindicacion 1: Una composicion farmacéutica que comprende: a) un compuesto de la formula (1), o una sal, solvato, hidrato o forma morfologica farmacéuticamente aceptable de éste, b) relleno, c) un desintegrante, d) un agente tensoactivo, y e) un lubricante. Reivindicacion 16: El uso de un compuesto de la formula (1) como se define en la reivindicacion 1, o una sal, un solvato, un hidrato o una forma morfologica de éste, para la preparacion de un medicamento, para ser utilizado en el tratamiento de hipertension arterial pulmonar.
ARP060103943A 1999-05-22 2006-09-11 Composicion farmaceutica estable que contiene una pirimidina-sulfamida AR057123A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP9903532 1999-05-22
US09/573,504 US6316453B1 (en) 1999-05-22 2000-05-18 Aqueous pharmaceutical composition

Publications (1)

Publication Number Publication Date
AR057123A1 true AR057123A1 (es) 2007-11-14

Family

ID=26070369

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103943A AR057123A1 (es) 1999-05-22 2006-09-11 Composicion farmaceutica estable que contiene una pirimidina-sulfamida

Country Status (12)

Country Link
US (1) US6316453B1 (es)
EP (1) EP1060749B1 (es)
JP (1) JP4632385B2 (es)
AR (1) AR057123A1 (es)
AT (1) ATE235255T1 (es)
CA (1) CA2308660C (es)
DE (1) DE60001768T2 (es)
DK (1) DK1060749T3 (es)
ES (1) ES2195818T3 (es)
NZ (1) NZ504671A (es)
PT (1) PT1060749E (es)
ZA (1) ZA200002318B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528065B2 (en) * 2006-01-17 2009-05-05 International Business Machines Corporation Structure and method for MOSFET gate electrode landing pad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW313568B (es) * 1994-12-20 1997-08-21 Hoffmann La Roche
EP0897914B1 (en) * 1997-08-19 2004-05-26 F. Hoffmann-La Roche Ag Process for the preparation of 2,5-disubstitued pyridines

Also Published As

Publication number Publication date
EP1060749A1 (en) 2000-12-20
PT1060749E (pt) 2003-08-29
JP4632385B2 (ja) 2011-02-16
ES2195818T3 (es) 2003-12-16
DE60001768T2 (de) 2003-10-16
ZA200002318B (en) 2000-11-16
US6316453B1 (en) 2001-11-13
NZ504671A (en) 2001-11-30
JP2001002564A (ja) 2001-01-09
CA2308660A1 (en) 2000-11-22
CA2308660C (en) 2008-08-12
DE60001768D1 (de) 2003-04-30
DK1060749T3 (da) 2003-06-23
ATE235255T1 (de) 2003-04-15
EP1060749B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
UY27682A1 (es) Composiciones farmacéuticas
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
BR0107869A (pt) Composições farmacêuticas eletrogiradas
SE8804629D0 (sv) New therapeutically active compounds
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
PE20001032A1 (es) Composiciones y metodos para tratar enfermedades pulmonares
AR033688A1 (es) Composicion parenteral reconstituible
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
JP2005520779A5 (es)
ATE248187T1 (de) Echinocandin-kohlenhydrate-komplexe
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
SE8804628D0 (sv) New compounds
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
AR057123A1 (es) Composicion farmaceutica estable que contiene una pirimidina-sulfamida
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas

Legal Events

Date Code Title Description
FC Refusal